Utility of dynamic contrast enhancement for clinically significant prostate cancer detection

Documenti analoghi

• PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
  di: Nicole Handa, et al.
  Pubblicazione: (2025)
• Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
  di: Austin Drysch, et al.
  Pubblicazione: (2025)
• AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
  di: Muhammad Imran, et al.
  Pubblicazione: (2026)
• Peak early‐phase enhancement ratio on contrast‐enhanced MRI to differentiate chromophobe renal cell carcinoma from oncocytoma
  di: Deanna Thorson, et al.
  Pubblicazione: (2025)
• MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
  di: Herbert Lepor, et al.
  Pubblicazione: (2025)